![]() |
市场调查报告书
商品编码
1827724
2025年全球透析设备市场报告Dialyzers Global Market Report 2025 |
近年来,透析设备市场规模稳定成长,从2024年的22.4亿美元增加至2025年的23.4亿美元,复合年增长率为4.5%。预测期内的成长归因于人口老化、医疗基础设施的改善、研发的加强以及透析中心数量的增加。
预计未来几年透析设备市场规模将强劲成长,2029年将达到30.6亿美元,复合年增长率为7.0%。预测期内的成长主要受以下因素驱动:慢性肾臟病率上升、可支配收入增加、医疗支出增加以及家庭透析治疗治疗需求的增加。预测期内的主要趋势包括穿戴式透析设备、人工智慧 (AI) 整合、远端监控、基于价值的护理模式以及生物工程。
透析机是医疗设备,用于在肾臟功能不正常时过滤废物并去除血液中多余的水分。它通过半透膜,利用不均匀扩散作用分离溶液中的化合物,从而取代肾臟。这个过程可以有效过滤肾衰竭患者血液中的污染物。
透析设备主要分为高透析设备和低通量透析设备两种。高通量透析透析设备孔径较大,能够去除较大的分子,例如β-2微球蛋白。这类透析设备分为一次性透析机和可重复使用透析机,可用于多种场合,包括中心透析、家庭透析治疗、血液透析机。
2025年春季美国关税突然上调及其引发的贸易摩擦,对医疗设备领域产生了重大影响,尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战进一步加剧了形势,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场准入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供透析设备市场统计数据,例如全球市场规模、区域份额、竞争对手的透析设备透析设备市场份额、详细的透析设备细分市场、市场趋势和机会,以及在透析设备行业取得成功所需的数据。本透析设备市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的一切观点。
未来五年7.0%的预测成长率,较我们先前对该市场的预测略有下降0.3%。下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自英国和丹麦等主要地区的中空纤维膜和生物相容性灌封胶征收关税直接影响美国,从而可能导致救命过滤装置短缺,并推高终末期肾病的治疗成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响,其影响将更为广泛。
末期肾功能衰竭(ESRF),也称为末期末期肾功能衰竭(ESRD) 的盛行率不断上升,代表着慢性肾臟病的最后不可逆阶段,此时透析设备功能下降到无法再独立运作的程度。透析是为了清除血液中的废物和多余的液体,并将过滤的血液送回体内。例如,2024 年 6 月,致力于预防可预防肾臟病的印度组织国家肾臟基金会报告称,到 2023 年,美国将有大约 3550 万人被诊断出患有慢性肾臟病,占成年人的 33%,即超过三分之一。此外,黑人/非裔美国人占美国人口的 13%,但占慢性肾臟病患者的 30%。肾臟病患者约占所有医疗保险支出的四分之一,总额达 1567 亿美元,而且还在增加。因此,末期肾功能衰竭的上升正在推动透析设备市场的成长。
糖尿病和心血管疾病的盛行率上升是透析设备市场成长的驱动力。糖尿病和心血管疾病会带来严重的健康风险,血糖值升高会增加心臟相关疾病的可能性。糖尿病和心血管疾病患者使用透析设备清除血液中的废物和多余液体,解决潜在的肾功能障碍和过滤障碍,从而控制併发症并改善整体健康。根据世界卫生组织 (WHO) 的数据,慢性病占全球死亡人数的 74%,每年导致 4,100 万人死亡。这些死亡包括 1,790 万人死于心血管疾病,930 万人死于癌症,410 万人死于慢性呼吸道疾病,200 万人死于糖尿病。糖尿病和心血管疾病发生率的上升正在推动透析设备市场的扩张。
为了确保可靠的患者照护,透析设备市场的主要企业正专注于开发血液相容性透析设备等创新产品。血液相容性透析设备经过特殊设计,可抑制血液凝固系统的活化和发炎反应,进而降低透析过程中併发症的风险,例如血栓、出血和感染疾病。例如,2024 年 2 月,德国製造商费森尤斯医疗保健股份公司推出了 5,008X血液透析机系统。该系统及其配套的 FX CorAL透析设备展示了该公司在医疗设备和膜工程创新方面的全球领导地位。 5008X血液透析机系统整合了先进的设备工程和薄膜技术,可实现大容量血液透析机。
透析设备市场的主要企业正在寻求策略伙伴关係关係,以改善末期肾功能衰竭(ESRD) 患者的生活品质 (QOL) 和整体患者照护体验。策略伙伴关係关係是指公司利用彼此的优势和资源,实现互利共赢。例如,2023 年 9 月,美国医疗科技公司 Alio Inc. 与美国医疗保健公司 Lifeline Vascular Care 合作,为其 SmartPatch 远端监控平台引入一项新功能。此功能会提醒临床医师注意患者血管通路部位的异常声学资料。此次合作旨在透过实现主动监控而无需频繁就诊,从而改善患者管理,特别是针对末期肾病 (ESKD) 患者。
另一项策略性倡议是,德国知名透析设备製造商 B. Braun SE 于 2022 年 3 月收购了 Intermedt Medizin & Technik GmbH,收购金额未揭露。此次策略性收购将使 B. Braun 能够获得 Intermedt 提供的全面透析产品和服务,从而加强和扩展产品系列。 Intermedt Medizin & Technik GmbH 是一家德国专业的透析设备和透析浓缩液製造商,将成为 B. Braun 在透析设备市场战略成长和发展不可或缺的一部分。透过此类策略倡议,透析设备市场的主要企业不仅在加强其产品供应,而且还在利用合作伙伴关係和收购来塑造终末期肾病领域患者照护的未来格局。
透析设备市场的一些主要企业包括美敦力公司、旭化成医疗株式会社、东丽医疗株式会社、百特国际公司、贝朗梅尔松根股份公司、泰尔茂株式会社、尼普洛株式会社、日机装株式会社、威高西克医疗有限公司、Xmedon 医疗产品公司、Emed 医疗公司医疗有限公司、医学有限公司、费森尤斯医疗公司医疗有限公司、Emed 医疗有限公司医疗有限公司、医学有限公司、Fxentage 医疗有限公司医疗公司医疗有限公司、医学 医疗有限公司医疗有限公司医疗有限公司、Fxentage 医疗有限公司医疗有限公司医疗有限公司医疗有限公司医疗有限公司、医学 医疗有限公司医疗有限公司)股份公司、川澄製药股份有限公司、Dialife SA、安徽金业实业有限公司、Haidylena 和 Farmasol SA。
2024 年,北美是透析设备市场最大的地区。报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。
透析设备市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。
透析设备市场由提供诸如去除多余液体和过滤血液中的废物等服务的营业单位所获得的收益所构成。市场规模还包括服务提供者销售或包含在其服务产品中的相关商品的价值。透析设备市场包括管式透析设备、平板式透析设备和中空纤维透析设备的销售。该市场的价值是“出厂价”,即商品製造商或生产商销售给其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。
A dialyzer is a medical device utilized for filtering waste chemicals and eliminating excess fluid from an individual's blood in cases where the kidneys are not functioning properly. It acts as a substitute for the kidneys by employing semipermeable membranes to separate compounds in solution through uneven diffusion. This process effectively filters pollutants from the bloodstream of patients with kidney malfunction.
The primary types of dialyzers are high-flux dialyzers and low-flux dialyzers. High-flux dialyzers feature larger holes, allowing them to remove larger molecules such as beta-2 microglobulin. These dialyzers can be categorized based on their usage as disposable or reusable and can be employed in various settings, including in-center dialysis, home dialysis, hospital dialysis, independent dialysis, peritoneal dialysis, and home hemodialysis.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The dialyzers market research report is one of a series of new reports from The Business Research Company that provides dialyzers market statistics, including dialyzers industry global market size, regional shares, competitors with a dialyzers market share, detailed dialyzers market segments, market trends and opportunities, and any further data you may need to thrive in the dialyzers industry. This dialyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The dialyzers market size has grown steadily in recent years. It will grow from $2.24 billion in 2024 to $2.34 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to aging population, improved healthcare infrastructure, rise in research and development, increase in number of dialysis centers.
The dialyzers market size is expected to see strong growth in the next few years. It will grow to $3.06 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing prevalence of chronic kidney diseases, rising disposable income, rising healthcare expenditure, growing demand for home dialysis treatment. Major trends in the forecast period include wearable dialysis devices, artificial intelligence (ai) integration, remote monitoring, value-based care models, bioengineered dialyzers.
The forecast of 7.0% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on hollow fiber membranes and biocompatible potting compounds, sourced from key regions such as the UK and Denmark, which could lead to shortages in life-saving filtration devices and higher costs for end-stage renal disease treatment.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of end-stage renal disease is anticipated to drive the growth of the dialyzer market in the near future. End-stage renal failure (ESRF), also known as end-stage renal disease (ESRD), represents the final, irreversible stage of chronic kidney disease, during which kidney function has declined to a level that the kidneys can no longer function independently. A dialyzer is utilized in the dialysis process to remove waste and excess fluid from the bloodstream, subsequently reinfusing the filtered blood back into the body of patients with end-stage renal disease. For example, in June 2024, the National Kidney Foundation, an organization based in India focused on combating preventable kidney disease, reported that nearly 35.5 million people in the US were diagnosed with chronic kidney disease by 2023, accounting for 33 percent of adults, or more than one in three. Additionally, while Black/African American individuals make up 13% of the U.S. population, they represent 30% of all kidney failure cases. Kidney patients receive about one-fourth of all Medicare expenditures, amounting to $156.7 billion and increasing. Thus, the rising incidence of end-stage renal disease is fueling the growth of the dialyzer market.
The rising rates of diabetes and cardiovascular disease are poised to propel the dialyzer market's growth. Diabetes and cardiovascular disease pose significant health risks, with elevated blood sugar levels contributing to an increased likelihood of heart-related conditions. Patients afflicted with diabetes and cardiovascular disease utilize dialyzers to eliminate waste products and excess fluids from their bloodstream, managing complications and enhancing overall health by addressing potential kidney dysfunction and impaired filtration. According to the World Health Organization, chronic diseases account for 74% of global fatalities, with 41 million deaths annually, encompassing 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. The mounting rates of diabetes and cardiovascular disease underscore the driving force behind the dialyzer market's expansion.
Major companies in the dialyzer market are concentrating on developing innovative products, such as hemocompatible dialyzers, to ensure reliable patient care. A hemocompatible dialyzer is specifically designed to reduce the activation of the blood's clotting system and the inflammatory response, thereby lowering the risk of complications during dialysis, including blood clots, bleeding, and infections. For example, in February 2024, Fresenius Medical Care AG & Co. KGaA, a German manufacturer of dialyzers, introduced the 5008X Hemodialysis System. This system and its accompanying FX CorAL dialyzer demonstrate the company's global leadership in innovation within medical device and membrane engineering technologies. The 5008X Hemodialysis System integrates advanced device engineering with membrane technologies to facilitate high-volume hemodiafiltration.
Major companies in the dialyzer market are pursuing a strategic partnership approach to enhance the quality of life and overall patient care experience for individuals with end-stage renal disease (ESRD). Strategic partnerships involve companies utilizing each other's strengths and resources to achieve mutual benefits and success. For example, in September 2023, Alio Inc., a US-based medtech company, collaborated with Lifeline Vascular Care, a US-based medical firm, to introduce a new feature for its SmartPatch remote monitoring platform. This feature alerts clinicians to unusual acoustic data from a patient's vascular access site. The goal of this partnership is to improve patient management, particularly for those with end-stage kidney disease (ESKD), by enabling proactive monitoring without the necessity for frequent in-person visits.
In another strategic move, B. Braun SE, a prominent Germany-based manufacturer of dialyzers, executed an acquisition in March 2022 by acquiring Intermedt Medizin & Technik GmbH for an undisclosed amount. This strategic acquisition positions B. Braun to fortify and expand its product portfolio by gaining access to the comprehensive range of dialysis products and services offered by Intermedt. As a Germany-based manufacturer specializing in dialyzers and dialysis concentrates, Intermedt Medizin & Technik GmbH becomes an integral component of B. Braun's strategic growth and development in the dialyzer market. Through such strategic initiatives, major companies in the dialyzer market are not only enhancing their product offerings but also leveraging collaborations and acquisitions to shape the future landscape of patient care in the realm of end-stage renal disease.
Major companies operating in the dialyzers market include Medtronic PLC, Asahi Kasei Medical Co Ltd., Toray Medical Co Ltd., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Nikkiso Co Ltd., Weigao group, Fresenius Medical Care AG & Co KGaA, Allmed Medical Products Co Ltd., NxStage Medical Inc., Jiangxi Sanxin Medical Technology Co Ltd., Rockwell Medical Inc., Xenios AG., Kawasumi Laboratories Incorporated., Dialife SA, Anhui Jinye Industrial Co Ltd., Haidylena, and Farmasol S.A
North America was the largest region in the dialyzers market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the Dialyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The dialyzer market consists of revenues earned by entities by providing services such as removal of excess fluid, filtering blood from waste products. The market value includes the value of related goods sold by the service provider or included within the service offering. The dialyzer market also consists of sales of tube-type dialyzers, flat-type dialyzers, and hollow fiber-type dialyzers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Dialyzers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on dialyzers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for dialyzers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dialyzers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.